What is Neuronetics's stock-based comp?

Neuronetics (STIM) reported stock-based comp of $1.68M in Q1 2026.

How has Neuronetics's stock-based comp changed year-over-year?

Neuronetics's stock-based comp increased by 16.1% year-over-year, from $1.44M to $1.68M.

What is the long-term trend for Neuronetics's stock-based comp?

Over 4 years (2021 to 2025), Neuronetics's stock-based comp has grown at a -3.4% compound annual growth rate (CAGR), from $7.87M to $6.85M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Neuronetics STIM Stock-Based Comp

Stock-Based Comp at other companies

LifeStance Health GroupLFST

$15.2M-18.2%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$2.57M+305%

StereotaxisSTXS

$2.11M-16.8%

Neuropace, Inc.NPCE

$2.28M-13.3%

Neurocrine BiosciencesNBIX

$57.2M+8.3%

ClearPoint NeuroCLPT

$2.22M+16.2%

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-56.2%

Enterprise value$162.64M-42.0%

P/S0.6×-1.3×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's stock-based comp?: Neuronetics (STIM) reported stock-based comp of $1.68M in Q1 2026.
How has Neuronetics's stock-based comp changed year-over-year?: Neuronetics's stock-based comp increased by 16.1% year-over-year, from $1.44M to $1.68M.
What is the long-term trend for Neuronetics's stock-based comp?: Over 4 years (2021 to 2025), Neuronetics's stock-based comp has grown at a -3.4% compound annual growth rate (CAGR), from $7.87M to $6.85M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.